These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 12828751)

  • 1. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
    Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
    J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
    Meltzer EO; Casale TB; Nathan RA; Thompson AK
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
    Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
    J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of terfenadine in relieving the pruritus of atopic dermatitis.
    Berth-Jones J; Graham-Brown RA
    Br J Dermatol; 1989 Nov; 121(5):635-7. PubMed ID: 2574594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
    Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
    Van Cauwenberge P; Juniper EF
    Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
    Casale TB; Andrade C; Qu R
    Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
    Zirwas MJ; Barkovic S
    J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis.
    Hjorth N
    Cutis; 1988 Oct; 42(4A):29-30. PubMed ID: 2903817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.